On the production plan of Covaxin at various facilities, NITI Aayog member (Health) Dr V K Paul said there were some initial hiccups related to standardisation and quality assurances of the batches of vaccines at the Bangalore plant of Bharat Biotech, which delayed the production of the anti-Covid vaccine.
